Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry
- PMID: 2959633
- DOI: 10.1007/BF00175298
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry
Abstract
The urinary excretion of doxifluridine (5'dFUrd) and its metabolites was determined during five days of chemotherapy using fluorine-19 nuclear magnetic resonance spectrometry. The daily urinary excretion of 5'dFUrd and its metabolites was high (congruent to 100% of the 5'dFUrd administered) and nearly constant throughout the treatment. By far the major excreted compounds were unchanged 5'dFUrd and alpha-fluoro-beta-alanine which made up respectively congruent to to 40% and congruent to to 50% of the total. Neither accumulation of 5'dFUrd nor significant modifications in its metabolism were observed during the treatment.
Similar articles
-
New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR.Cancer Chemother Pharmacol. 1984;13(1):31-5. doi: 10.1007/BF00401443. Cancer Chemother Pharmacol. 1984. PMID: 6234105
-
19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans.Drug Metab Dispos. 1988 Jan-Feb;16(1):78-84. Drug Metab Dispos. 1988. PMID: 2894959
-
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance.Clin Chem. 1985 Jun;31(6):846-8. Clin Chem. 1985. PMID: 3922650
-
Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids.Chemotherapy. 2006;52(5):215-9. doi: 10.1159/000094744. Epub 2006 Jul 25. Chemotherapy. 2006. PMID: 16864998 Review.
-
Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.Clin Chim Acta. 2006 Apr;366(1-2):61-73. doi: 10.1016/j.cca.2005.10.013. Epub 2005 Dec 6. Clin Chim Acta. 2006. PMID: 16337167 Review.
Cited by
-
Mass balance studies, with a focus on anticancer drugs.Clin Pharmacokinet. 2006;45(1):33-58. doi: 10.2165/00003088-200645010-00003. Clin Pharmacokinet. 2006. PMID: 16430310 Review.
-
Uses and limitations of nuclear magnetic resonance (NMR) spectroscopy in clinical pharmacokinetics.Clin Pharmacokinet. 1991 May;20(5):337-49. doi: 10.2165/00003088-199120050-00001. Clin Pharmacokinet. 1991. PMID: 1879094 Review. No abstract available.